- Home
- RGNX vs LAES Comparison
RGNX vs LAES Comparison
Compare RGNX & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | LAES |
|---|---|---|
| Founded | 2008 | 2022 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 761.9M | 821.2M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | RGNX | LAES |
|---|---|---|
| Price | $8.03 | $3.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $29.13 | $7.00 |
| AVG Volume (30 Days) | 1.2M | ★ 9.6M |
| Earning Date | 03-12-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $161,318,000.00 | $10,978,000.00 |
| Revenue This Year | $128.55 | $64.88 |
| Revenue Next Year | $47.33 | $94.93 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 91.30 | N/A |
| 52 Week Low | $5.04 | $1.99 |
| 52 Week High | $16.19 | $8.71 |
Technical Indicators
Market Signals| Indicator | RGNX | LAES |
|---|---|---|
| Relative Strength Index (RSI) | 24.36 | 43.81 |
| Support Level | $10.15 | $3.50 |
| Resistance Level | $8.63 | $4.20 |
| Average True Range (ATR) | 0.79 | 0.29 |
| MACD | -0.35 | -0.03 |
| Stochastic Oscillator | 6.92 | 30.31 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.